Right to Try laws allow Big Pharma to exploit patients' hope

“Right to Try laws allow Big Pharma to exploit patients’ hope,” Diana Zuckerman, Chicago Tribune.

If you were dying of a terminal illness and your doctor said there were no proven treatments, would you take the risk of trying an experimental, unproven drug? Many patients would say yes. But as with most medical decisions, the . . . → Read More: Right to Try laws allow Big Pharma to exploit patients’ hope

Book Review: Hospital Land USA

Death is certain. Time of death is not. But in Hospital Land USA, the other S&M (Science and Medicine) as Wendy Simonds calls it, death is a failure, something to be suspended and avoided at whatever cost. And there is no safe word. The surreal ordinariness of it all – from appointments and forms to . . . → Read More: Book Review: Hospital Land USA

Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer

“Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer,” Mary Chris Jaklevic, Health News Review.

Genetic testing for breast and ovarian cancer risk is cheaper and easier than ever. But just because a test is available doesn’t mean everyone should get it. That message didn’t come through in a recent series of . . . → Read More: Advocacy group anecdotes present one-sided picture of genetic testing for breast cancer

Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice

PAGES: 1 2 3

Is Childlessness Really Another Side Effect of Cancer?

The emphasis on biological motherhood in the field of oncofertility masks at least two societal forces contributing to the cancer/infertility equation.

First, the conditions in which people live and work are are already linked to cancers and adverse effects on women’s . . . → Read More: Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice – 3

Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice

PAGES: 1 2 3

Rethinking Normative Expectations

As professionals, we have to balance our responsibility to care, inform and research for safer fertility treatments while respecting women’s choices that may at times go against dominant models of womanhood. In doing so, it is crucial to acknowledge several problems stemming from norms about reproduction . . . → Read More: Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice – 2

Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice

PAGES: 1 2 3

Cancer and cancer treatments can have a huge impact on women’s sexual and reproductive health. Yet, when I started my research on breast cancer and social inequality in Spain a decade ago this issue was hardly being addressed in international scholarly debates or in clinical settings. Several of the . . . → Read More: Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice

Panel Reasserts Mammogram Advice That Triggered Breast Cancer Debate

“Panel Reasserts Mammogram Advice That Triggered Breast Cancer Debate,” The New York Times, Jan. 11, 2016.

In 2009, the United States Preventive Services Task Force (an independent volunteer board of doctors and other experts appointed by the Department of Health and Human Services to evaluate screening tests, counseling, and medications . . . → Read More: Panel Reasserts Mammogram Advice That Triggered Breast Cancer Debate

Spotlight: Think Before You Pink

Think Before You Pink®, launched in 2002, is a project of Breast Cancer Action in response to growing concerns about pink ribbon commercialization and the glut of pink ribbon products on the market.

What we love about Think Before You Pink is that it begins to hold people accountable for their role in the breast . . . → Read More: Spotlight: Think Before You Pink

The full story on breast cancer screening. But do you want to listen?

“The full story on breast cancer screening. But do you want to listen?,” by Kenneth Lin, MD, MedPage Today’s KevinMD.com.

The Men Against Breast Cancer Fund and several cancer advocacy and physician organizations have posted a petition on Change.org asking Congress to place a two-year moratorium on finalizing the U.S. Preventive Services Task Force’s draft . . . → Read More: The full story on breast cancer screening. But do you want to listen?

Screening for breast cancer? That will be $1,500

“Screening for breast cancer? That will be $1,500,” by Beth Wolfensberger Singer, The Boston Globe.

Graphic arts engage readers in a way that text cannot. Told with a sequences of pictures, along with narration and dialogue (often in the form of speech bubbles), graphic arts have become increasingly popular media for education and communication . . . → Read More: Screening for breast cancer? That will be $1,500

Articles & Posts